@article{2b95dd0f04f946babe09a71261bb61fa,
title = "Mortality reduction with PCSK9 inhibition: A case of cautious optimism",
author = "Dixon, {Dave L.} and Virani, {Salim S.}",
note = "Funding Information: Sources of funding: This work was supported by research funding from the Department of Veterans Affairs Health Services Research & Development (IIR 16-072). This work was also supported by the Houston VA HSR&D Center for Innovations grant (HFP 90-020). Financial Disclosures: Dr Virani has received honorarium from the American College of Cardiology (Associate Editor for Innovations, acc.org). He also serves on the steering committee for the Patient and Provider Assessment of Lipid Management (PALM) registry at the Duke Clinical Research Institute (no financial remuneration).",
year = "2019",
month = sep,
day = "1",
doi = "10.1016/j.jacl.2019.06.012",
language = "English",
volume = "13",
pages = "712--713",
journal = "Journal of Clinical Lipidology",
issn = "1933-2874",
publisher = "Elsevier BV",
number = "5",
}
